Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study

Abstract

Few lung transplant recipients achieved a serological response to three COVID-19 vaccine doses, indicating a need for other protective measures. Older age and use of mycophenolate or corticosteroids were associated with absence of a response. The low incidence of COVID-19 might reflect vaccine protection <i>via</i> cellular immunity and/or good adherence to shielding measures.